Comment: Massive Theophylline Dosing

Hendeles L Weinberger M Szefler S Ellis E . Safety and efficacy of theophylline in children with asthma. J Pediatr 1992; 120: 177–83.

Juniper EF Kline PA Vanzieleghem MA Ramsdale EH O'Bryne PM Hargreave FE . Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics. Am Rev Respir Dis 1990; 142: 832–6.

Haahtela T Järvinen M Kava T Kiviranta K Koskinen S Lehtonen K Comparison of a β₂-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991; 325: 388–92.

Barnes PJ . A new approach to the treatment of asthma. N Engl J Med 1989; 321: 1517–27.

National Asthma Program. Expert panel report: Guidelines for the diagnosis and management of asthma. Bethesda, MD: National Heart, Lung and Blood Institute, 1991; 81(publication no. 91–3042).

Schucard DW Spector SL Euwer RL Cummins KR Schucard JL Friedman A . Central nervous system effects of antiasthma medication: An EEG study. Ann Allergy 1985; 54: 177–84.

Weinberger M Hendeles L . Slow-release theophylline: Rationale and basis for product election. N Engl J Med 1983; 308: 760–4.

Derby LE Jick SS Langlois JC Johnson LE Jick H . Hospital admission for xanthine toxicity. Pharmacotherapy 1990; 10: 112–4.